Charles River Laboratories International Inc
Research Charles River Laboratories International Inc (CRL) on Bullrun: market cap USD 14.21B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCRL
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 14.21B
- Financial periodQ2 2026
- RevenueUSD 1.00B
- Net income-USD 1.48M
- Free cash flowUSD 148.62M
- Gross margin36.2%
Valuation Snapshot
latest market cap is USD 14.21B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.02B | -USD 144.34M | USD 518.49M | 33.0% | -2.91 | USD 213.77M | USD 166.00K | USD 3.16B |
| FY2024 | USD 4.05B | USD 22.20M | USD 501.61M | 32.9% | 0.2 | USD 194.61M | USD 155.00K | USD 3.46B |
| FY2023 | USD 4.13B | USD 474.62M | USD 365.37M | n/a | 9.22 | USD 276.77M | USD 3.17M | USD 3.60B |
| FY2022 | USD 3.98B | USD 486.23M | USD 294.91M | n/a | 9.48 | USD 233.91M | USD 1.35M | USD 2.98B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 14.21B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.82B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.44B | 710.0 | n/a | n/a |
| 2023 | 2023-12-29 | USD 12.13B | 25.6 | n/a | n/a |
| 2022 | 2022-12-30 | USD 11.09B | 25.7 | n/a | n/a |
| 2021 | 2021-12-31 | USD 19.02B | 49.6 | n/a | n/a |
About Charles River Laboratories International Inc
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Charles River Laboratories International Inc's market cap?
Charles River Laboratories International Inc's market capitalization is USD 14.21B.
What does Charles River Laboratories International Inc do?
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers.